openPR Logo
Press release

Partial Epilepsy Market to Reach USD 9.36 Billion by 2034

12-05-2025 04:07 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Partial Epilepsy Market

Partial Epilepsy Market

Pune, India - December 2025 - The global Partial Epilepsy Market, valued at USD 5.84 billion in 2024, is projected to reach USD 9.36 billion by 2034, growing at a 4.8% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of focal (partial) seizures, development of improved anti-epileptic drugs (AEDs), and advancements in neuroimaging and neuromodulation therapies are key growth drivers.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72067

Market Summary
The Partial Epilepsy Market is expanding steadily as physicians adopt newer anti-seizure medications, precision diagnostics, and minimally invasive neuromodulation treatments for patients with focal epilepsy. Partial epilepsy-characterized by seizures originating from a specific brain region-accounts for the majority of epilepsy cases globally. While traditional AEDs remain widely used, demand is increasing for next-generation therapies offering better seizure control, fewer side effects, and improved tolerability, including brivaracetam, lacosamide, cenobamate, perampanel, and long-acting formulations.

Diagnostic improvements such as high-resolution MRI, PET/SPECT imaging, video EEG, and AI-based seizure pattern analysis are enabling earlier and more accurate diagnosis. For drug-resistant cases, vagus nerve stimulation (VNS), deep brain stimulation (DBS), responsive neurostimulation (RNS), and laser ablation are gaining traction. North America leads the market, while Asia-Pacific is emerging rapidly due to rising awareness and expanding epilepsy treatment centers.

Key Takeaways
• 2024 Market Size: USD 5.84 Billion
• 2034 Forecast: USD 9.36 Billion
• CAGR: 4.8% (2025-2034)
• Newer anti-seizure medications driving treatment advancements
• Neuromodulation therapies gaining adoption for drug-resistant epilepsy
• Asia-Pacific showing strong growth due to expanding diagnostic capabilities

Explore Full Report here:
https://exactitudeconsultancy.com/reports/72067/partial-epilepsy-market

Market Drivers
• Rising global prevalence of epilepsy, especially focal seizures
• Expanding portfolio of effective and better-tolerated anti-seizure medications
• Advancements in neurodiagnostics and seizure-monitoring systems
• Increased adoption of RNS, VNS & DBS for refractory epilepsy
• Growing awareness and improved access to specialized epilepsy centers

Segmentation Snapshot
By Drug Class
• Sodium Channel Blockers
• SV2A Ligands (Brivaracetam, Levetiracetam)
• GABA Modulators
• AMPA Antagonists
• Mixed-Mechanism AEDs
• Others

By Treatment
• Anti-Seizure Medications (Primary Share)
• Neuromodulation Therapies (VNS, DBS, RNS)
• Surgical Interventions
• Supportive & Psychological Care

By Diagnostic Method
• MRI & CT Imaging
• EEG & Video EEG
• PET/SPECT
• Neurophysiological Monitoring
• AI-Based Seizure Detection Tools

By End User
• Hospitals
• Neurology Clinics
• Epilepsy Treatment Centers
• Home Care
• Research Institutions

By Region
• North America (Largest Market)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa

Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72067

Recent Developments
• Cenobamate showing strong outcomes in drug-resistant partial epilepsy.
• AI-based EEG interpretation tools gaining FDA clearance.
• Growth in minimally invasive laser ablation procedures.
• Expanded reimbursement for neuromodulation devices.

Expert Quote - Irfan Tamboli, Business Development Executive
"Breakthrough medications and advanced neuromodulation technologies are significantly improving seizure control for partial epilepsy patients. Earlier diagnosis and precision treatment strategies are shaping the future of epilepsy care."

Conclusion
The Partial Epilepsy Market will continue to grow through 2034 as innovative anti-seizure drugs, advanced neuroimaging technologies, and neuromodulation therapies enhance treatment outcomes. Companies investing in precision medicine, AI diagnostics, and next-generation AEDs will drive the future landscape.

This report is also available in the following languages : Japanese (部分てんかん市場), Korean (부분 간질 시장), Chinese (部分性癫痫市场), French (Marché de l'épilepsie partielle), German (Markt für partielle Epilepsie), and Italian (Mercato dell'epilessia parziale), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72067

Our More Reports:

Intracranial Pressure Monitoring Devices Market
https://exactitudeconsultancy.com/reports/72113/intracranial-pressure-monitoring-devices-market

Migraine Market
https://exactitudeconsultancy.com/reports/72115/migraine-market

Sacral Nerve Stimulation Devices Market
https://exactitudeconsultancy.com/reports/72117/sacral-nerve-stimulation-devices-market

Transcranial Doppler Market
https://exactitudeconsultancy.com/reports/72119/transcranial-doppler-market

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Partial Epilepsy Market to Reach USD 9.36 Billion by 2034 here

News-ID: 4303172 • Views:

More Releases from Exactitude Consultancy

Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitation and Infrastructure Projects
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250 Key Market Highlights • Increasing focus on road maintenance and resurfacing projects • Growing demand for efficient and precision milling
Credit Management Software Market Accelerates as Organizations Focus on Risk Mitigation and Cash Flow Optimization
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248 Key Market Highlights • Growing adoption of automated credit risk assessment tools • Increasing focus on working capital and cash flow management • Integration
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Operators Strengthen Network Security
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246 Key Market Highlights • Growing adoption of VoIP and
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Traction Amid Global Decarbonization Efforts
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244 Key Market Highlights • Rapid growth of

All 5 Releases


More Releases for Partial

Partial Discharge Measurement Camera | SM Instruments
SM Instruments provides a fixed outdoor partial discharge camera for detecting gas leaks and faults. It performs well even in harsh, wet, or cold environments. SM Instruments BATCAM FX Fixed Ultrasonic Acoustic Camera for Outdoor Gas Leak and Partial Discharge Detection The BATCAM FX is a fixed ultrasonic camera designed for continuous outdoor monitoring of gas leaks, electrical faults, and partial discharges, even in harsh environments such as cold, wet, or noisy industrial
Partial Hospitalization Program Treatment
When it comes to addiction treatment, there are different levels of care. These levels of care vary depending on how intense the patient’s addiction is. These levels of care also vary based on structure intensity. For example, individuals that suffer from severe addictions will need to receive care through inpatient or residential treatment programs. The next most intensive and structured form of addiction treatment after inpatient and residential treatment is
Ultrasonic Camera for Partial Discharge Detection| SM INSTRUMENTS
Specialized Ultrasonic Camera BACTAM for partial discharge detection is available in SM Instruments Inc. SM Instruments is a Gold Alliance Partner of the National Instruments of the US since its foundation in 2006. The main technologies of SM Instruments are visualization of sound using the sound camera, and detection of Buzz, Squeak, and Rattle using BSR Tools. What is the Partial discharge Partial discharge (PD) is a localized dielectric breakdown of a
Activated Partial Thromboplastin Market Overview by 2020-2026
Scope of the Report: The worldwide market for Activated Partial Thromboplastinis expected to grow at a CAGR of roughly x% over the next five years, will reach x million US$ in 2024, from x million US$ in 2019, according to a new Global Info Researchstudy. The report presents the market outlook for the Indian Phospho Gypsum product from the year 2019 to the year 2025. The report provides a definition of the
Components of full or partial automatic stripping machine
1. The principle of work for full or partial automatic stripping machine: Transmission wire through inlet wire wheel and outlet wire wheel and complete the cutting and stripping with knife rest assembly. 2. Brief introduction to main components function: (1) Inlet wire wheel uplift knob: uplift inlet wire wheel while full or partial automatic stripping machine‘s threading, turn the knob clockwise to raise up inlet wire wheel, so that you can smoothly pass
Trends and Forecast Update on Point-of-Care Partial Thromboplastin Time and Acti …
Point of care Partial Thromboplastin Time (PTT) and Activated Partial Thromboplastin Time (APTT) testing are majorly performed at the patient’s site. It provides rapid tests for the tests such as partial thromboplastin and activated partial thromboplastin as compared to other laboratory testing techniques. In addition, point of care offers immediate and convenient patient diagnosis option. Partial thromboplastin time test is primarily used to measure the blood clotting time of the